L L Augsburger

Clarification of nomenclature.

L E Small, L L Augsburger, 1977, Journal of pharmaceutical sciences.

Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration.

A S Hussain, L L Augsburger, A. Hussain, 1998, Journal of controlled release : official journal of the Controlled Release Society.

The role of intra- and extragranular microcrystalline cellulose in tablet dissolution.

L L Augsburger, L. Augsburger, G S Rekhi, 1996, Pharmaceutical development and technology.

Evaluation of "external" predictability of an in vitro-in vivo correlation for an extended-release formulation containing metoprolol tartrate.

A S Hussain, L L Augsburger, P. Marroum, 2000, Journal of pharmaceutical sciences.

Capsule filling machine simulation. I. Low-force powder compression physics relevant to plug formation.

L L Augsburger, L. Augsburger, P. Heda, 1999, Pharmaceutical development and technology.

Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets.

L L Augsburger, L J Lesko, G S Rekhi, 1998, Pharmaceutical development and technology.

Plastic flow during compression of directly compressible fillers and its effect on tablet strength.

L L Augsburger, L. Augsburger, S T David, 1977, Journal of pharmaceutical sciences.

Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations.

L L Augsburger, L J Lesko, L. Lesko, 1997, Pharmaceutical development and technology.

Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets.

A S Hussain, L L Augsburger, A. Hussain, 1999, Journal of controlled release : official journal of the Controlled Release Society.

Practical Limitations of Tableting Indices

L L Augsburger, S W Hoag, R Kuppuswamy, 2001, Pharmaceutical development and technology.